Opinion
Video
Insights from the COORDINATE-Diabetes Trial
Key Takeaways
- The trial focused on improving cardiovascular risk management in type 2 diabetes through a coordinated care model.
- Structured care pathways and multidisciplinary teams were key interventions to enhance guideline adherence.
A panel of experts explores the objectives and design of the COORDINATE-Diabetes trial, discussing its potential impact on the treatment paradigm for diabetes management.
Video content above is prompted by the following:
- Tell us about the COORDINATE-Diabetes trial.
- What were the objectives of COORDINATE-Diabetes and how was the trial designed?
- What interventions were provided?
- What were the results of the study?
- What are future opportunities to improve CRM care based on this trial?
This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
Related Content
